Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study.
Over a 2-year period, a predeposit autologous blood transfusion service was provided for all patients undergoing elective surgery for left-sided colonic or rectal cancer in one hospital. Of 129 such patients, 28 were suitable for autologous donation. Eight of these received autologous blood only, 13 required no transfusion, and seven needed additional homologous blood. Thus, although predeposit autologous transfusion for patients with colorectal cancer is possible, only a very small proportion are likely to derive any benefit which it might confer.
Harrison
S
S
Department of Surgery, University Hospital, Queen's Medical Centre, Nottingham, UK.
Steele
R J
RJ
Johnston
A K
AK
Jones
J A
JA
Morris
D L
DL
Hardcastle
J D
JD
D000368:Aged; D001804:Blood Transfusion, Autologous / Q000379:methods*; D003110:Colonic Neoplasms / Q000601:surgery*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D011379:Prognosis; D012004:Rectal Neoplasms / Q000601:surgery*